The Food and Drugs Authority (FDA) has warned consumers to remain cautious when purchasing palm oil due to continuing concerns over adulteration.

This comes on the back of the FDA's efforts to eliminate the presence of the hazardous 'Sudan IV', an industrial substance banned in food products due to its carcinogenic properties, that has been detected in some palm oil products circulating on the market."

The Deputy Chief Executive Officer of the FDA Roderick Daddey-Adjei revealed that despite the efforts to eliminate the product from the market, challenges persist.

 “But we are still not happy about that small percentage that is there, which means that people who perpetrated the activity are still lurking in the dark,” Mr. Daddey-Adjei stated.

He however emphasised the FDA's commitment to tackling the issue.

“We want to also let those who think that they can come back and keep on doing this, that their days are numbered,” Mr. Daddey-Adjei said.